News

A global biopharmaceutical company headquartered in London announced the layoffs of 150 Massachusetts employees last week.
British biopharmaceutical company GlaxoSmithKline will lay off 150 employees in its Cambridge operations by the end of March 2026, the company said in a notice to the state. The company said Monday ...
Amid plans to transfer manufacturing for an investigational vaccine to a souped-up plant in Pennsylvania, GSK is parting ways ...
GSK is laying out €250 million to bolster vaccine manufacturing with a new facility to help make free-dried shots, including for shingles and RSV.
Hundreds of GSK workers have voted to stage a series of walkouts at U.K. manufacturing sites in May over a pay dispute, in what could be a first at the company, Reuters tells us.
Big Pharma firm GSK plans to invest up to $800 million to expand its manufacturing operations in Pennsylvania and create 200 new jobs.
We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other ...
We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now.In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other ...
GlaxoSmithKline (NYSE: GSK) recently announced this year that it has acquired Okairos AG (Okairos), a specialist developer of vaccine platform technologies for €250 million (approximately £215 ...